Motilal Oswal Financial Services has reiterated its BUY recommendation for Sun Pharma, assigning a 12-month target price of Rs 1,960, with the stock currently trading at Rs 1,690.
Motilal Oswal, a leading research house, has reiterated a BUY call on Mahindra & Mahindra (M&M) with a target price of Rs 4,122, citing robust earnings, margin expansion, and strong growth
Motilal Oswal Financial Services has reiterated a BUY rating on Rural Electrification Corporation (RECL), emphasizing stable asset quality, consistent earnings growth, and a robust future loan book
Motilal Oswal Research has upgraded Tata Steel (TATA) to a BUY rating, with a target price of Rs 210, implying a 19% upside from the current market price of Rs 177.